Trial participants also reported that the experimental glucagon was easy to use in the two late-phase trials. -Craig Idlebrook/GluCraig Data from two new studies provide evidence that nasal glucagon could be an effective treatment for hypoglycemia in a real-world setting. The two Phase III studies, funded by Eli Lilly and Locemia Solutions, aimed to gauge whether […]
The move corrects a strange regulatory gap in Medicare coverage.
Medicare Will Allow Dexcom G5 CGM to Be Used with Smart, Mobile Devices